NRIX- Nurix Therapeutics, Inc.

Name: Nurix Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Nurix Therapeutics, Inc. (NRIX) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. NRIX is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Other	Hansen Gwenn	117.0K	$1.92M	-3,214
CFO	Van Houte Hans	54.0K	$885.6K	-2,388
Dir	Dansey Roger D	50.0K	$819.5K	-
Other	Ring Christine	26.5K	$433.6K	-8,608
Dir	Kapur Anil	25.0K	$409.8K	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
May 1, 2026	Ring Christine78	Chief Legal Officer	Sell	5,394	$16.76	$90,406.68	-16.9%	-	-
Apr 30, 2026	Hansen Gwenn74	Chief Scientific Officer	Sale+OE	3,214	$16.65	$53,497.99	-2.6%	-	-
Apr 30, 2026	Ring Christine78	Chief Legal Officer	Sale+OE	3,214	$16.65	$53,497.99	-9.2%	-	-
Apr 30, 2026	Van Houte Hans62	Chief Financial Officer	Sale+OE	2,388	$16.65	$39,748.98	-4.4%	-	-
Jan 30, 2026	Ring Christine78	Chief Legal Officer	Sale+OE	4,421	$16.60	$73,381.12	-3.7%	+1.1%	-
Jan 30, 2026	Hansen Gwenn74	Chief Scientific Officer	Sale+OE	4,895	$16.60	$81,249.16	-2.8%	+1.1%	-
Jan 30, 2026	Van Houte Hans62	Chief Financial Officer	Sale+OE	3,661	$16.60	$60,766.50	-3.9%	+1.1%	-
Dec 18, 2025	Ring Christine78	Chief Legal Officer	Sale+OE	3,760	$17.90	$67,314.32	-3.6%	-16.4%	-
Nov 24, 2025	Ring Christine78	Chief Legal Officer	Sale+OE	37,600	$17.07	$641,696.64	-42.5%	-10.3%	-
Nov 3, 2025	Van Houte Hans62	Chief Financial Officer	Sell	6,284	$12.56	$78,931.44	-14.3%	+35.4%	-

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC